Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Berggren

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Infection and Immunity|June 24, 2005
Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosisIsis K Mullarky, Frank M Szaba, Kiera N Berggren, et al.
Neurology|February 15, 2024
Neurobehavioral Phenotype of Children With Congenital Myotonic DystrophyNamita Patel, Kiera N Berggren, Man Hung, et al.
Infection and Immunity|January 24, 2006
Tumor necrosis factor alpha and gamma interferon, but not hemorrhage or pathogen burden, dictate levels of protective fibrin deposition during infectionIsis K Mullarky, Frank M Szaba, Kiera N Berggren, et al.
Muscle & Nerve|June 15, 2018
Orofacial strength, dysarthria, and dysphagia in congenital myotonic dystrophyKiera N Berggren, Man Hung, Melissa M Dixon, et al.
Neurology. Clinical Practice|November 22, 2019
Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1Nicholas E Johnson, Eugenio Zapata Aldana, Nathalie Angeard, et al.
Neurology. Genetics|April 6, 2026
Toward Trial Readiness in Congenital Myotonic Dystrophy: A Longitudinal Cohort Study of Predictors of Motor Function in ChildhoodMichael Kiefer, Julia M Hartman, Kiera N Berggren, et al.
Journal of Neuromuscular Diseases|January 8, 2024
The Early Care (0-3 Years) In Duchenne Muscular Dystrophy Meeting ReportNiki Armstrong, Susan Apkon, Kiera N Berggren, et al.
The Journal of Clinical Investigation|January 21, 2025
The Splice Index as a prognostic biomarker of strength and function in myotonic dystrophy type 1Marina Provenzano, Kobe Ikegami, Kameron Bates, et al.
Muscle & Nerve|December 20, 2020
12-Month progression of motor and functional outcomes in congenital myotonic dystrophyKellen H Quigg, Kiera N Berggren, Melissa McIntyre, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2004
Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2Wayne W Hancock, Frank M Szaba, Kiera N Berggren, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Infection and Immunity|June 24, 2005
Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosisIsis K Mullarky, Frank M Szaba, Kiera N Berggren, et al.
Neurology|February 15, 2024
Neurobehavioral Phenotype of Children With Congenital Myotonic DystrophyNamita Patel, Kiera N Berggren, Man Hung, et al.
Infection and Immunity|January 24, 2006
Tumor necrosis factor alpha and gamma interferon, but not hemorrhage or pathogen burden, dictate levels of protective fibrin deposition during infectionIsis K Mullarky, Frank M Szaba, Kiera N Berggren, et al.
Muscle & Nerve|June 15, 2018
Orofacial strength, dysarthria, and dysphagia in congenital myotonic dystrophyKiera N Berggren, Man Hung, Melissa M Dixon, et al.
Neurology. Clinical Practice|November 22, 2019
Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1Nicholas E Johnson, Eugenio Zapata Aldana, Nathalie Angeard, et al.
Neurology. Genetics|April 6, 2026
Toward Trial Readiness in Congenital Myotonic Dystrophy: A Longitudinal Cohort Study of Predictors of Motor Function in ChildhoodMichael Kiefer, Julia M Hartman, Kiera N Berggren, et al.
Journal of Neuromuscular Diseases|January 8, 2024
The Early Care (0-3 Years) In Duchenne Muscular Dystrophy Meeting ReportNiki Armstrong, Susan Apkon, Kiera N Berggren, et al.
The Journal of Clinical Investigation|January 21, 2025
The Splice Index as a prognostic biomarker of strength and function in myotonic dystrophy type 1Marina Provenzano, Kobe Ikegami, Kameron Bates, et al.
Muscle & Nerve|December 20, 2020
12-Month progression of motor and functional outcomes in congenital myotonic dystrophyKellen H Quigg, Kiera N Berggren, Melissa McIntyre, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2004
Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2Wayne W Hancock, Frank M Szaba, Kiera N Berggren, et al.
Pageof 3